This correlates tightly with the EC50 for AHR activation by kynurenine in COS-1 cells (13 μM)16, and the EC50 of kynurenine to drive Cyp1A1 expression in U87 glioma cells (12.3 μM)2. This evidence concerns the gene AHR and central nervous system cancer.